← Back to Clinical Trials
Recruiting NCT05975775

NCT05975775 Outpatient Laparoscopic Radical Prostatectomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05975775
Status Recruiting
Phase
Sponsor GCS Ramsay Santé pour l'Enseignement et la Recherche
Condition Prostate Cancer
Study Type OBSERVATIONAL
Enrollment 64 participants
Start Date 2023-10-20
Primary Completion 2026-10

Eligibility & Interventions

Sex Male only
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Laparoscopic radical prostatectomy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 64 participants in total. It began in 2023-10-20 with a primary completion date of 2026-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of the study is to evaluate the incidence of surgery-related complications between Day 0 and Day 30.

Eligibility Criteria

Inclusion Criteria: * Male, age ≥ 18 years; * Localized prostate cancer; * Validation in a multidisciplinary consultation meeting of curative treatment; * Scheduled laparoscopic radical prostatectomy; * Patient able to understand the information related to the study, to read the information leaflet and to signify his/her non-opposition or opposition to participating in the study; * Membership of a social security scheme; * Patient having been informed and having given oral non-opposition. Exclusion Criteria: * Surgical emergency; * Patient not eligible for ambulatory care; * Long-term curative anti-coagulant treatment; * Resident more than 100km from the clinic; * Home alone the first night; * Patient under guardianship, curatorship or deprivation of liberty.

Contact & Investigator

Central Contact

Arnaud BALDINI, MD

✉ docteur.baldini@urolyon-ouest.fr

📞 469001019

Frequently Asked Questions

Who can join the NCT05975775 clinical trial?

This trial is open to male participants only, aged 18 Years or older, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05975775 currently recruiting?

Yes, NCT05975775 is actively recruiting participants. Contact the research team at docteur.baldini@urolyon-ouest.fr for enrollment information.

Where is the NCT05975775 trial being conducted?

This trial is being conducted at Lyon, France.

Who is sponsoring the NCT05975775 clinical trial?

NCT05975775 is sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. The trial plans to enroll 64 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology